Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017

Kennen MacKay Initiated (ANAB) at Buy and Held Target at $40 on, Sep 15th, 2017

Kennen MacKay of RBC Capital, Initiated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $40 on, Sep 15th, 2017.

Kennen has made no other calls on ANAB in the last 4 months.



There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 0 agree with Kennen's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Kennen


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $38 on, Friday, August 25th, 2017
  • Neena Bitritto-Garg of "Baird" Initiated at Buy and Held Target at $36 on, Tuesday, July 11th, 2017